Zobrazeno 1 - 10
of 120
pro vyhledávání: '"unfractioned heparin"'
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Backgrounds: Anticoagulation in sepsis-associated disseminated intravascular coagulation (DIC) remains uncertain. The aim of this study was to investigate whether unfractioned heparin (UFH) could improve clinical outcomes in patients with sepsis-indu
Externí odkaz:
https://doaj.org/article/aa47bb1e7b95452e9c94d7c194692711
Autor:
Liu, Michael
Publikováno v:
Side Effects of Drugs Annual
As of September 9, 2020, Worldwide coronavirus disease 2019 (COVID-19) has caused 894 000 deaths with over 27.5 million confirmed cases. There is an urgent need for effective treatment. Considerable efforts have been placed on developing novel therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_________::4d2a46568b1b2c302d46c9430572d294
http://europepmc.org/articles/PMC7833628
http://europepmc.org/articles/PMC7833628
Autor:
Konrad Hoetzenecker, André Pausch, Marion Wiegele, Friedrich Erhart, Peter Jaksch, Eva Schaden, Johannes Gratz, Andreas Baierl
Publikováno v:
Artificial Organs
Extracorporeal membrane oxygenation (ECMO) is gaining importance in the perioperative management of lung transplant patients. To date, the ideal substance for anticoagulation of ECMO patients is still a matter of debate. In this study, we describe ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22a92bea7e654fc2db26f72e0e04db5
https://pubmed.ncbi.nlm.nih.gov/31951030
https://pubmed.ncbi.nlm.nih.gov/31951030
Heparinem indukovaná trombocytopenie je vzácnou komplikací léčby jak nefrakcionovaným heparinem (UFH), tak nízkomolekulárním heparinem (LMWH). Protilátky proti komplexu heparin-trombocytový faktor 4 hrají hlavní úlohu v patogenezi, při
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______8936::3047ae34ff823a6e849c09732bb26dde
http://hdl.handle.net/11025/42918
http://hdl.handle.net/11025/42918
Publikováno v:
Annual Update in Intensive Care and Emergency Medicine ISBN: 9783030373221
An appropriate anticoagulation strategy is crucial to ensure safe and uninterrupted continuous renal replacement therapy (CCRT) sessions. In fact, filter clotting remains the principal reason for unplanned circuit replacement and unintentional interr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d09e0314e710b3cf6c996a1d3310ff4
https://doi.org/10.1007/978-3-030-37323-8_28
https://doi.org/10.1007/978-3-030-37323-8_28
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mohannad Abdulrazzaq Alalwan, Ibrahim Ali I. Alasseri, Abdullah Obaid Binobaid, Adel Mushref Ali Alharban, Bashayer Ateya Al-Harthy, Nareman Suliman Shamlan, Fatema Salman Hasan Salman Khalaf, Ali Mohammed A. Alasmari, Balgaith H. Albareqi, Kawther Abdulroof Alabbas, Yousef Mohammed Alhazmi, Meryem Safi, Haider Issa Alaqaili, Maan Ahmed Alsaaid
Publikováno v:
The Egyptian Journal of Hospital Medicine. 69:2455-2458
Anticoagulation is the mainstay treatment of pulmonary embolism. Using low molecular weight heparin versus unfractionated heparin remains a matter of debate. Objectives: the aim of this review is to study the prognosis of using low molecular weight v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0e975d8337de3f704a1259d3a2ef1b5
https://doi.org/10.12816/0041693
https://doi.org/10.12816/0041693
Publikováno v:
Акушерство, гинекология и репродукция, Vol 10, Iss 1, Pp 26-37 (2016)
The article describes the main anticoagulant drugs used in cancer patients, taking into consideration pathogenetic aspects of hypercoagulation status in cancer patients: oral anticoagulants, heparin drugs, selective inhibitors of Xa factor. The basic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6422ec12e5f909d8e781218ee73cc85b
https://doi.org/10.17749/2313-7347.2015.10.1.026-037
https://doi.org/10.17749/2313-7347.2015.10.1.026-037
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of unfractioned heparin without routine use of provisional glycoprotein inhibitor compared to bivalirudin, in patients with acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a944828582d1531fae24f216eb13af
https://europepmc.org/articles/PMC6491337/
https://europepmc.org/articles/PMC6491337/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.